Table 2.

Univariate Cox-regression model for overall survival.

Variable		n	Hazard ratio (95%CI)	p
Age		151	1.07 (1.04–1.11)	<0.0001
Sex	Female vs. male	54	1.10 (0.66–1.83)	0.712
ECOG	≥2 vs. 0, 1	6	3.14 (1.23–8.03)	0.0167
Grading	High-grade vs. low-grade	94	2.27 (1.18–4.35)	0.011
Tumor stage	≥pT2 vs. < pT2	74	3.45 (2.05–5.79)	<0.0001
Lymph node metastases	pN+ vs. pN0	25	5.13 (2.57–10.24)	<0.0001
Resection margins	R1/R2/Rx vs. R0	22	6.37 (3.58–11.36)	<0.0001
Cis	Cis vs. No Cis	25	1.77 (0.98–3.21)	0.06
Lymphovascular invasion	Yes vs. No	29	2.96 (1.35–6.48)	0.0067
Localization	Ureter vs. kidney pelvis vs. multiple	39	0.62 (0.32–1.22)	0.116
		24	0.84 (0.42–1.66)	0.819
Lymphadenectomy	Yes vs. No	86	0.97 (0.51–1.82)	0.751
Hydronephrosis	Yes vs. No	75	1.19 (0.73–1.94)	0.487
Mitomycin C instillation	Yes vs. No	26	0.30 (0.09–0.96)	0.0428
Bladder cuff excision	Yes vs. No	122	0.37 (0.22–0.63)	0.00022

Bold and italics values indicate significant differences with p-values <0.05.